{"title":"[Interventional studies on acute-on-chronic liver failure: challenges and opportunities].","authors":"P F Yu, M M Xu, Y Chen","doi":"10.3760/cma.j.cn501113-20240902-00465","DOIUrl":null,"url":null,"abstract":"<p><p>Acute-on-chronic liver failure (ACLF) is a kind of complex syndrome characterized by acute deterioration of liver function on the basis of chronic liver disease, accompanied by organ failure and a high mortality rate. The International Society for Hepatology has proposed different definitions, diagnostic criteria, and treatment guidelines, which have led to differences in the clinical management of ACLF and underestimated the burden of the disease. Currently, there is no specific treatment for ACLF, and the overall prognosis is still not ideal. This article profoundly explores the problems existing in the interventional studies of ACLF and provides a new perspective for in-depth research on the pathogenesis and progression, the development of new intervention measures, the promotion of personalized treatment, and the formulation of more accurate diagnostic criteria and risk prediction models.</p>","PeriodicalId":24006,"journal":{"name":"中华肝脏病杂志","volume":"32 12","pages":"1067-1072"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华肝脏病杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn501113-20240902-00465","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Acute-on-chronic liver failure (ACLF) is a kind of complex syndrome characterized by acute deterioration of liver function on the basis of chronic liver disease, accompanied by organ failure and a high mortality rate. The International Society for Hepatology has proposed different definitions, diagnostic criteria, and treatment guidelines, which have led to differences in the clinical management of ACLF and underestimated the burden of the disease. Currently, there is no specific treatment for ACLF, and the overall prognosis is still not ideal. This article profoundly explores the problems existing in the interventional studies of ACLF and provides a new perspective for in-depth research on the pathogenesis and progression, the development of new intervention measures, the promotion of personalized treatment, and the formulation of more accurate diagnostic criteria and risk prediction models.
急性慢性上肝衰竭(ACLF)是在慢性肝病的基础上,以肝功能急性恶化为特征,伴脏器功能衰竭,病死率高的一种复杂综合征。国际肝病学会(International Society for Hepatology)提出了不同的定义、诊断标准和治疗指南,导致ACLF的临床管理存在差异,并低估了该病的负担。目前,ACLF尚无特异性治疗方法,整体预后仍不理想。本文深入探讨了ACLF介入研究中存在的问题,为深入研究ACLF的发病进展、开发新的干预措施、促进个性化治疗、制定更准确的诊断标准和风险预测模型提供了新的视角。